US 10464967
Non-hormonal steroid modulators of NF-κβ for treatment of disease
granted A61KA61K31/573A61K31/58
Quick answer
US patent 10464967 (Non-hormonal steroid modulators of NF-κβ for treatment of disease) held by ReveraGen BioPharma, Inc. expires Mon Oct 31 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- ReveraGen BioPharma, Inc.
- Grant date
- Tue Nov 05 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 31 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 4
- CPC classes
- A61K, A61K31/573, A61K31/58, A61P, A61P19/02